OCT 16, 2015 8:56 AM PDT

A Cure for Ebola?

WRITTEN BY: Kerry Evans
This isn’t the first time I’ve written about Ebola (and it probably won’t be the last).  Recently, a number of techniques for quickly diagnosing Ebola have been developed, and could make it to market in the (hopefully near) future.  Until now, however, there has been little progress towards vaccines or therapeutics for the virus.  Researchers at the US Army Medical Research Institute of Infectious Diseases and Gilead Sciences isolated a compound called GS-5734 that cured monkeys of Ebola virus disease (EVD).  
 
GS-5734 is a promising Ebola therapeutic.

Ebola virus causes a devastating hemorrhagic fever in humans and non-human primates, where the average survival rate is about 50%.  Clinicals symptoms include fever, headaches, vomiting, and bleeding, both internal and external.  Death often results from low blood pressure and overall fluid loss.  

GS-5734 is a nucleotide analog that inhibits the viral RNA polymerase, but does not affect host polymerases (an important consideration).  The group first tested the ability of GS-5734 to inhibit Ebola virus replication in human cell culture.  Next, they treated one group of Ebola-infected monkeys with 3 mg/kg of GS-5734, but only 50% of them survived.  They treated a second set of monkeys with a higher dose of the drug, 10 mg/kg, and all of the monkeys survived.  Clinical symptoms of EVD such as excessive bleeding were also reduced.  Although viral load was significantly decreased, it does not appear that the monkeys were “cured” of the virus.

GS-5734 was also effective against other Filoviruses such as Marburg, indicating it could serve as a broad-spectrum anti-viral.  However, the fact that Ebola virus was still detectable in the “cured” monkeys leaves me only cautiously optimistic.      

Check out the following video for information on Ebola gene-silencing technology being developed in Canada by Tekmira.  
 

Sources: ID Week 2015, Medical News Today, Genome Web, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
AUG 25, 2020
Drug Discovery & Development
The Potential of Antivitamins
AUG 25, 2020
The Potential of Antivitamins
What exactly are antivitamins? They are substances no less that have the power to target the biological function of a ge ...
OCT 04, 2020
Microbiology
A Virus Can Disrupt a Carb-Consuming Gut Microbe
OCT 04, 2020
A Virus Can Disrupt a Carb-Consuming Gut Microbe
Not all viruses affect animal cells; some viruses can infect bacteria. Humans are known to carry vast numbers of microor ...
OCT 22, 2020
Microbiology
SARS-CoV-2 Has Multiple Routes Into Cells
OCT 22, 2020
SARS-CoV-2 Has Multiple Routes Into Cells
Since the pandemic virus SARS-CoV-2 emerged on the scene late last year, it's left a trail of devastation around the glo ...
OCT 26, 2020
Microbiology
A Network of Fungi Helps Trees Grow
OCT 26, 2020
A Network of Fungi Helps Trees Grow
Trees rely on a network of fungal friends for good health. Communities of trees can share nutrients and other essentail ...
NOV 05, 2020
Clinical & Molecular DX
Painless Microneedle Patch Diagnoses Malaria in Minutes
NOV 05, 2020
Painless Microneedle Patch Diagnoses Malaria in Minutes
It looks like a Band-Aid — a small, adhesive patch that is applied directly to the skin. This simple, low-cost dia ...
NOV 08, 2020
Genetics & Genomics
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
NOV 08, 2020
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
Researchers have found that drug-resistant bacteria can hang around even after deep cleaning. They used genome sequencin ...
Loading Comments...